title: B cell treatments for multiple sclerosis.
authors.affiliation: Institute of Psychological Medicine and Clinical, Neurosciences, Cardiff University, Cardiff, CF14 4XW, UK.
authors.forename: D
authors.initials: D
authors.lastname: McLauchlan
authors.affiliation: Institute of Psychological Medicine and Clinical, Neurosciences, Cardiff University, Cardiff, CF14 4XW, UK. robertsonnp@cardiff.ac.uk.
authors.forename: N P
authors.initials: NP
authors.lastname: Robertson
mesh_terms: D000293:Adolescent; D000328:Adult; D000074323:Alemtuzumab / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000502:physiology*; D015331:Cohort Studies; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000068556:Interferon beta-1a / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000000981:diagnostic imaging / Q000628:therapy*; D055815:Young Adult
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000074323:Alemtuzumab; C533411:ocrelizumab; D000068556:Interferon beta-1a